← Leaderboards
Moustafa Gabr
Weill Medical Coll Of Cornell Univ
$7,041,425
Attributed
$7,041,425
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.5M · FY2024–25$5M$3.8M$2.5M$1.3M$0
'24
'25
Funding mix
By agency
NIH$7,041,425 · 5
By mechanism
R01$5,061,047 · 4
RF1$1,980,378 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Augustine M Choi$36,719,348
- Nicholas M Adams$84,454
- Mark Owyong$97,232
- Alfred Choon Kit Chin$108,512
- Xiaojing Ma$8,449,948
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposEvaluationIn VitroMouse ModelScreeningDrug KineticsSmall MoleculeBindingLead OptimizationNanomolarCellsInvestigationPositioning AttributeSmall Molecule InhibitorInhibitorNovel Therapeutic InterventionClinical TrialsIn VivoExcretory FunctionFluorescenceProtocols DocumentationEnergy TransferMetabolismAbsorption
Grant awards (10)
Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease$744,923
R01 · FY2025 · AG · contact PI
Optimization of small molecule immunomodulators as combination therapy for IBD$664,128
R01 · FY2025 · DK · contact PI
Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma$548,232
R01 · FY2025 · CA · contact PI
CHI3L1-targeted small molecules for glioblastoma$502,588
R01 · FY2025 · NS · contact PI
Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease (supplement)$110,202
R01 · FY2025 · AG · contact PI
Small molecule inhibitors of CAPON-induced tau aggregation$1,980,378
RF1 · FY2024 · AG · contact PI
Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease$768,267
R01 · FY2024 · AG · contact PI
Optimization of small molecule immunomodulators as combination therapy for IBD$672,432
R01 · FY2024 · DK · contact PI
Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma$547,687
R01 · FY2024 · CA · contact PI
CHI3L1-targeted small molecules for glioblastoma$502,588
R01 · FY2024 · NS · contact PI